Sort
141,003 grants matching “cytokine”
Drug Delivery Techniques
$1,511,881Edward H Oldfield · Neurological Disorders And Stroke · Z01 · FY2007 · NS
Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy
$1,511,798Richard T D'aquila · Northwestern University At Chicago · P01 · FY2021 · AI
Immunotherapeutic Approaches for AIDS
$1,511,661George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
HIV-1 SHEDDING FROM FEMALE GENITAL TRACT
$1,511,632University Of Washington · P01 · FY2003 · HD
Genomics of Kidney Transplantation
$1,511,561Arthur J Matas · University Of Minnesota · U19 · FY2009 · AI
Stanford/UNC Biomimetic U19 Research Center
$1,511,551Calvin J Kuo · Stanford University · U19 · FY2022 · AI
Mechanisms of Asthma Pathogenesis and Treatment
$1,511,242Stewart Levine · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
9.4 Tesla Fourier Transform Mass Spectrometer
$1,511,150University Of Alabama At Birmingham · S10 · FY2002 · RR
Cell Interactions in Three Dimensional Tissue Culture
$1,510,692Leonid B. Margolis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
The connection of innate and adaptive anti-cancer immunity
$1,510,560John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
The Dry Eye Evaluation And Management (DREAM) Study: Coordinating Center
$1,510,104Maureen G Maguire · University Of Pennsylvania · U10 · FY2016 · EY
Immune Regulation in Mycobacterial and Fungal Infections
$1,509,737Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Regulation of mucosal immunity by neuronal pathways
$1,509,513David Artis · Weill Medical Coll Of Cornell Univ · U01 · FY2022 · AI
Immune Dysregulation in Allergic Asthma
$1,508,900University Of New Mexico · P50 · FY2005 · HL
Genomic regulation of immune response in neurodegeneration in mice
$1,508,785Han-Yu Shih · National Eye Institute · ZIA · FY2022 · EY
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$1,507,995Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
$1,505,935Linda J Van Eldik · University Of Kentucky · R01 · FY2020 · AG
Evaluation of HIV-1 Vaccine Candidates in Macaca mulatta
$1,505,898Lindsay M. Wohlers · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2009 · AI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma
$1,505,841Ray Stokes Peebles · Vanderbilt University Medical Center · U19 · FY2020 · AI
Advancing RNA Therapeutics for Huntingtonâs Disease
$1,505,798Neil Aronin · Univ Of Massachusetts Med Sch Worcester · U01 · FY2021 · NS
Preclinical Development of an Anti-Mucus Drug
$1,504,184Michael Jay Holtzman · Washington University · UH3 · FY2017 · HL
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia
$1,504,126Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · R01 · FY2012 · HL
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$1,503,131Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Asthma Sample Collection Protocol: Defining the Role of Apolipoprotein Pathways in Asthma
$1,503,104Stewart Levine · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Childhood Neurodegenerative Lysosomal Storage Disorders
$1,503,084Anil B Mukherjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD